] and low-density lipoprotein which is associated with atherothrombotic disease. Lp(a) plasma levels are controlled to a large extent by the apo(a) gene locus. Known polymorphisms in the apo(a) gene, including the kringle (K) IV-2 variable number of tandem repeats, explain only part of the large interindividual variability and do not explain the differences in Lp(a) concentrations between major human ethnic groups. Here we performed screening for single nucleotide polymorphisms (SNPs) in exons and flanking intron sequences of the apo(a) K IV types 6, 8, 9 and 10 which represent 1.3 kb of coding sequence in two African (Khoi San, Black South Africans) and one Caucasian (Tyroleans) populations and investigated whether they affect Lp(a) levels. Together, 768 alleles were analyzed. We identified 14 SNPs, including 11 non-synonymous SNPs (eight of which involved conserved residues), one splice site and two synonymous base changes. No sequence variants common to Africans and Caucasians were found. Several of the newly identified SNPs showed significant effects on Lp(a) plasma concentrations. The substitutions S37F in K IV-6 and G17R in K IV-8 were associated with Lp(a) levels significantly below average in Africans. In contrast, the R18W substitution in K IV-9, which occurred with a frequency of 8% in Khoi San, resulted in a significantly increased Lp(a) concentration. Together, our data suggest that several SNPs in the coding sequence of apo(a) affect Lp(a) levels. This indicates that many SNPs may have subtle effects on the gene product.
INTRODUCTION
Human apolipoprotein(a) [apo(a)] is a glycoprotein containing 10 different types of kringle (K) IV domains which share a high degree of homology with plasminogen K IV (1) . One of these (K IV-2) occurs in multiple tandemly repeated copies which vary in number in apo(a). Apo(a) circulates in plasma covalently bound to LDL, forming the lipoprotein(a) [Lp(a)] particle which has atherosclerotic and prothrombotic properties. High levels of Lp(a) are associated with myocardial infarction, stroke, peripheral vascular disease and childhood thromboembolism (reviewed in 2).
Lp(a) levels show a large variability within a population with >1000-fold differences between individuals. Average Lp(a) concentrations are higher in Africans than in non-Africans and their distributions differ markedly between populations e.g. from a Gaussian distribution in Khoi San to distributions highly skewed toward lower concentrations in Caucasians and most Asians (3) (4) (5) (6) .
Twin and sib-pair analyses have revealed that the variation in Lp(a) concentrations is under almost complete genetic control and largely determined by variation at the apo(a) gene locus (7) (8) (9) (10) (11) . Three polymorphisms in the apo(a) gene with causal effects on Lp(a) levels have been identified so far. The number of K IV-2 repeats, which is reflected in the size of the protein, is inversely correlated to Lp(a) plasma concentrations in all studied populations (3,4,6,12, reviewed in 13) . Cell studies have shown that a lower secretion rate of the larger apo(a) isoforms from hepatocytes underlies the observed effect (14) (15) (16) (17) . However, depending on the population sample and the type of analysis, the K IV-2 VNTR explains only from 30 to 70% of the variability of Lp(a) concentrations in a population (13) . For alleles with identical numbers of K IV repeats, the Lp(a) level can differ by a factor of 200 (18) . Remarkably, average Lp(a) concentrations associated with apo(a) alleles with identical K IV-2 repeat number are higher in Africans than in Caucasians (3, 4) . Taken together, this suggests that sequence variation contributes to Lp(a) level variability. To date, two SNPs with clearly established causal effects on Lp(a) concentrations have been identified in humans. One is the +93 C→T substitution in the upstream untranslated region of apo(a) which introduces an alternative start codon (19) but may also affect transcription (20) . This polymorphism was found to have an impact on Lp(a) levels in Africans but not in Caucasians, where the effect was masked by linkage disequilibrium (21) . The other is a donor splice site mutation in K IV-8 which results in a null allele (22) .
Neither of these two polymorphisms either alone or in combination can explain the enormous Lp(a) concentration variability between individuals and among populations. Therefore, in addition to these polymorphisms, other sequence variations of the apo(a) gene which might differ between ethnic groups are expected to affect Lp(a) plasma levels. This scenario is strongly supported by the presence of polymorphisms in the non-coding regions of the gene e.g. a PNRP and SNPs in the 5′ flanking region and the DraIII restriction polymorphism in K IV-2 introns, which reportedly are associated with Lp(a) concentration, probably through allelic associations with unidentified mutations with causal effects (23) (24) (25) . A factor supposed to influence Lp(a) plasma levels is the efficiency of Lp(a) assembly.
Therefore, a candidate region for sequence variants related to the Lp(a) concentration is the domain of the apo(a) gene essential for Lp(a) particle formation. Lp(a) assembly requires two steps of interaction between apo(a) and apolipoprotein B-100 (apoB-100) of low-density lipoprotein (LDL) (reviewed in 26). As shown by in vitro studies with recombinant apo(a) deletion mutants, in the first step apo(a) binds non-covalently to lysinerich structures in apoB-100 via the unique K IV types 6-8 (27) (28) (29) . The non-covalent association between both macromolecules is followed by a single disulphide bridge formed between Cys45 in K IV-9 of apo(a) and Cys 4326 of apoB-100 (30, 31) . With this in mind we performed a systematic SNP analysis of exons from K IV types 5, 6, 8, 9 and 10 in African (South African Blacks, Khoi San) and Caucasian (Austrians) populations. Of particular interest was K IV-10, because the fibrin(ogen) binding properties of K IV-10 are thought to mediate the pathogenicity of Lp(a) (32) (33) (34) . Sequence variation in this kringle might be related to the heterogeneity in the lysine/fibrin binding affinity observed for different Lp(a) subtypes (35) (36) (37) . A mutation in the lys binding site (W72R) has been described in apo(a) with reduced fibrin binding from two individuals (38) . Arginine is present in this position in the chimpanzee which has an apo(a) K IV-10 devoid of lysine/fibrin binding capacity (39) . Moreover, when mice were made transgenic for a form of apo(a) containing Arg in this position of K IV-10 the animals became resistant to atherosclerosis (33) . All these findings implicate the K IV 6-10 domain of apo(a) as functionally important. Some of the newly identified SNPs in the apo(a) K IV domain reported here have a significant influence on Lp(a) plasma concentrations suggesting that they are of physiological significance.
RESULTS

Characterization of the intron sequences flanking the exons of the unique apo(a) kringles
The coding sequences of apo(a) kringles IV are characterized by their high degree of homology to each other and to the K IV of plasminogen (1) . Partial intron sequences are presently only available for K IV types 1-4 (40) . Therefore, to find unique annealing sites for specific amplification of both exons of K IV types 6, 8, 9 and 10 and to ensure detection of potential mutations over the whole coding sequences and splice sites, we partially sequenced the introns of K IV types 5-10 and used the intron sequences for primer design. (The sequencing data are available from GenBank.) The splice site sequences of the introns of the apo(a) unique kringles are of the GT-AG type and are analogous to those of plasminogen K IV (41) , as shown in Figure 1 . Despite the high sequence homology between the K IV exons, our sequencing analysis revealed that only those parts of the introns which flank the exons are highly conserved (Fig. 1) .
Screening for SNPs using denaturing gradient gel electrophoresis (DGGE)
The exons of apo(a) K IV types 6, 8, 9 and 10 were amplified by PCR of genomic DNA (Table 1 ) and analyzed for mutations using DGGE. Attachment of GC-clamps at the 5′ or 3′end of the fragments leading to a homogenous melting profile makes a considerable contribution to the high sensitivity of the method (42) . To avoid the predicted low melting domains within some of the analyzed sequences after attachment of only one GC-clamp we modified the method by including GC-clamps of different sizes at both ends of the fragments (Fig. 1 ). This resulted in homogeneous melting maps and thereby ensured detection of potential mutations over the entire length of fragments.
In our search for SNPs in the unique apo(a) kringles we screened three populations (Tyroleans, South African Blacks and Khoi San). Each population sample was initially represented by more than 100 unrelated randomly selected individuals. The PCR fragments showing a variant DGGE pattern were sequenced. As shown in Table 2 , we identified two synonymous base substitutions, nine non-synonymous base substitutions, two known non-synonymous exchanges and a donor splice site mutation described in detail elsewhere (22) . Two of the non-synonymous substitutions which result in T66M in K IV-10 (43) and T23P in K IV-8 (22, 44) have been reported previously. The T23P polymorphism was designated K IV-8 T12P by Prins et al. (44) , but this is not consistent with the numbering used by others (1) . Most of the mutations had frequencies >2% and therefore can be considered as SNPs. All SNPs were in Hardy-Weinberg equilibrium. However, S6I and P71T in K IV-9 and the silent mutation in K IV-10 were detected only in single Caucasian or African individuals, respectively. Interestingly there were no mutations common to Caucasians and Africans, while most of the mutations identified in Khoi San, an evolutionary old human group, were also present in South African Blacks. They were either of similar frequency (G17R, M75T) in Khoi San and African Blacks or frequencies of the rare allele were much higher in Khoi San (K IV-8 R45Q; K IV-9 R18W).
Among 768 tested alleles we did not find unknown variants resulting in amino acid changes in K IV-10. DGGE analysis of this kringle revealed only one silent mutation in a single Tyrolean (data not shown) and the previously described T66M polymorphism (43) . The W72R substitution found in two white Americans and associated with a lysine binding defect (38, 45) was not observed either in the tested Caucasian population or in Africans. 
Effect of the identified mutations on Lp(a) plasma concentrations
Lp(a) concentrations, apo(a) isoforms (by protein typing), the K IV-2 VNTR (by PFGE/genomic blotting) and some intragenic polymorphisms were known in the studied population samples (3, 21, 23) . Therefore, using two different statistical approaches it was possible to estimate whether the newly identified SNPs in the apo(a) unique kringles affect Lp(a) levels independent from known polymorphisms. However, formal statistical analysis was not possible for P52L, S6I and P71T substitutions which were all found in single subjects. Three out of six SNPs detected in Africans were found to contribute significantly to Lp(a) concentration variability ( Table 3 ). The S37F substitution in K IV-6 detected only in Khoi San, and the K IV-8 G17R substitution present in Khoi San and South African Blacks, were both associated with significantly lower Lp(a) plasma levels for the less common allele (P = 0.034 for S37F; P = 0.0033 for G17R). There was a stepwise decrease consistent with a gene dose effect from heterozygous to homozygous individuals compared with the wild-type subjects. When the effect of the apo(a) K IV repeat polymorphism was considered, the difference in the concentrations between the wild-type and mutant genotype groups remained significant (P = 0.038 for S37F; P = 0.0044 for G17R). This clearly demonstrates that the mutations have effects on Lp(a) concentration which are independent of the K IV-2 VNTR. The effect of the G17R substitution reached significance for both tests only in the pooled African sample but not in the individual populations (Table 3) . This is most likely explained by the low frequency of the rare allele (2.6% in South African Blacks; 2.9% in Khoi San). In both populations the influence of the variant on Lp(a) levels was in the same direction and of the same magnitude. Because of this and since Lp(a) levels were not significantly different between Khoi San and Black Africans for any G17R genotype, we considered pooling of the two samples justified.
The R18W substitution in K IV-9 was the only substitution where the minor allele was associated with Lp(a) levels significantly above the average (Table 3) . Compared with wild-type individuals mean Lp(a) concentrations were higher in the heterozygotes, and 2-fold increased in the homozygous mutation carriers (P = 0.031). Again, stratification for K IV repeats did not change the result (P = 0.033). Therefore, the effect of this SNP was not influenced by the size polymorphism of the apo(a) gene either.
The K IV-8 45Q allele was also associated with increased Lp(a) levels in Khoi San. However, this was significant only upon direct comparison (P = 0.0067; Table 3 ) but not after correction for the K IV effect (P > 0.08). In South African Blacks, the R45Q substitution did not affect Lp(a) levels (P = 0.35), which might be explained by the lower frequency of the 45Q allele in Blacks (3.3%) versus Khoi San (11%). Also in the pooled African sample an effect was only seen in the unstratified data, but not when corrected for the K IV-2 effect. In Khoi San the R45Q SNP in K IV-8 was found to be in strong linkage disequilibrium with the R18W SNP in K IV-9. More than 80% of the 45Q carriers also had the R18W substitution. Interestingly Gln at this position of the kringle is present in K IV of plasminogen and in apo(a) K IV types 6, 7, 9, and 10. Therefore, this mutation can be considered as a 'reversal' to the plasminogen K IV type. Alternatively, it might be the older one despite its lower frequency. Together, this suggests that the R18W site in K IV-9 is the SNP which causally affects Lp(a) levels and that the inconsistent effect of the R45Q substitution is caused by the allelic association with R18W.
The recently reported T23P substitution in K IV-8 (44) was found in Tyroleans with a frequency of 17% ( Table 2 ). The direct comparison of Lp(a) levels between the wild-type and mutant genotype groups did not show a significant difference (P > 0.06; Table 4 ). When the data were stratified for the effect of the K IV repeats, the 23P allele was associated with significantly decreased Lp(a) levels (P = 0.0022). The lower than expected Lp(a) levels were, however, only seen in homozygotes for 23P but not in heterozygotes which, in contrast, had higher Lp(a) than the wild-type. This inconsistency argues for a chance finding.
To test if any effect of the T23P substitution on Lp(a) levels could be seen in another Caucasian population, we included 104 unrelated Finnish individuals in the study.
This group was analyzed by a rapid restriction assay based on the introduction of a HaeIII site by the mutation (44) . In the Finnish population the polymorphism had an allele frequency of 11.5%. In the Finns, Lp(a) levels did not differ between T23P genotypes whether compared directly or following stratification for the K IV-2 VNTR on the basis of the size alleles (Table 4) . Therefore, the effect observed in the Tyroleans most likely has arisen by chance.
The very conservative change V91A in K IV-6 and the M75T SNP polymorphism in K IV-9 found in Africans did not show effects on Lp(a) levels (P > 0.4 for V91A; P > 0.35 for M75T, data not shown).
A possible effect on Lp(a) concentration of the P52L change could not be statistically analyzed since the mutation was identified in only two Tyroleans (Table 2) . However, we noted that the Lp(a) levels of both individuals were strikingly lower than expected on the basis of the size alleles (Table 5 ). We also noted that both individuals had one allele with 11 PNRs. Such alleles are rare and are associated with very low Lp(a) in Caucasians (23, 24) . However, the PNRP has no direct effect on Lp(a) levels and it has therefore been suggested that a causal mutation is in linkage disequilibrium with PNR11 (24, 46) . Both subjects with 52L and PNR11 possessed one non-expressed ('null') apo(a) allele with 22 K IV repeats 
revealed by PFGE and immunoblotting and they were also heterozygous for the T23P SNP, suggesting that both mutations in exon 1 of K IV-8 (66A→C and 154C→T) might be in cis. This was confirmed by cloning of the PCR products and subsequent sequencing of the inserts (data not shown). The allelic association between the less common sites together with the much lower frequency of 52L indicates that the latter is more recent and therefore it is likely that 52L is present on the apo(a) haplotype common to both individuals i.e. the allele with 22 K IV repeats found to be non-expressed. Hence, 52L might be the causal mutation responsible for the low Lp(a) associated with 11 PNRs. Family studies and in vitro expression of the mutant apo(a) forms will be necessary to confirm this assumption.
Analysis of allelic association
We tested for allelic associations between the newly identified SNPs and between these SNPs and other known polymorphisms in apo(a) by an exact test employing maximum likelihood calculations (56) . It has already been mentioned above that allelic associations exist between several of the analyzed polymorphisms which makes identification of putative causal mutations difficult. The substitutions of S37F and G17R were found to be associated with Lp(a) levels below the average in Africans, an effect that was independent from the K IV-2 polymorphism of the apo(a) gene. In Khoi San we found an allelic association (P < 0.0083) between S37F in exon 1 of K IV-6 and G17R in exon 1 of K IV-8. However, the minor alleles 37F and 17R are in repulsion indicating that the Lp(a) lowering effects of these mutations are independent from each other. As described above R45Q and R18W are also in strong linkage disequilibrium in Khoi-San which may explain the marginal but non significant association of 45Q with higher average Lp(a) levels. Another known polymorphism responsible for a causal reduction of Lp(a) concentrations and present in this population is the +93C→T change in the 5′ untranslated region of the apo(a) gene (21) . We therefore tested whether allelic association between the +93T site and the newly identified mutations in the unique kringles might explain the observed decrease of the Lp(a) levels. No allelic association of the SNPs with the +93C→T polymorphism was detected.
Allelic associations were further observed between SNPs and the K IV-2 repeat polymorphism e.g. in Caucasians the K IV-8 T23P is associated with the K IV-VNTR. Within the group of 23P mutation carriers from both Caucasian populations (Tyroleans and Finns) the frequencies of the apo(a) K IV-2 alleles ranging between 21 and 25 K IV repeats were significantly higher than expected (P < 0.001 for both groups) while larger K IV-2 alleles had a lower than expected frequency (P < 0.05).
DISCUSSION
The apo(a) gene and protein contain three major domains. (i) The protease domain, which is of unknown functional significance; (ii) the 5.6 kb K IV-2 domain, which is characterized by extensive variation in copy number (2 to greater than 30) and hence difficult to analyze for mutations; and (iii) the so-called unique kringle domain comprising K IV-1 and K IV types 3-10 and K V (1).
Here we have analyzed a part of the coding region and adjacent intronic sequences of the unique kringle domain for SNPs. The aim was to see with which frequency they occur, whether they are present in different frequencies in Africans and Caucasians and whether such polymorphisms might have an impact on Lp(a) concentrations and hence be of functional significance. Due to the presence of apo(a) in a complex [Lp(a)] with widely varying but genetically determined concentrations, the apo(a) gene is an ideal model to study whether SNPs have subtle effects on the gene product. Prins et al. (47) recently analyzed the K IV types 5-10 domain in one European population. These authors used primers in the K IV exons. They identified three sequence variants (R60S, L87V and L101V) in K IV-7. The latter two were in complete linkage disequilibrium. Furthermore, they observed one SNP in K IV-8 (T12P according to their numbering, T23P in this paper) and a variant (Y2F) in K IV-10. There was no indication of an effect on Lp(a) levels for either of these. We have not analyzed K IV-7 here and did not observe the K IV-10 Y2F substitution in our study. This may be due to the low frequency of the minor allele or due to population differences. Both K IV Y2F and K IV-7 R60S are rare, occurring with a frequency of 1% in the Dutch population (47) . In our study, which investigates the frequencies of sequence variants and their effects on Lp(a) levels in three human groups (Khoi San, a Black African population and a European population) of distinct positions in the presumed evolutionary tree of modern humans, we observed striking differences in SNP patterns, frequencies and effects on Lp(a) concentrations among populations.
An average of more than 200 independent alleles from each of three populations, i.e. a total of 768 alleles were screened. In the eight exons and flanking regions (representing 1328 bp coding sequence) we identified a total of 14 SNPs, 13 in coding sequences (cSNPs). One SNP which has been reported previously (22) occurred at a splice site. The density of SNPs (1/95 bp; nucleotide diversity θ = 14.6 × 10 -4 ) in this part of the coding sequence of apo(a) is in the higher range seen for many other human genes (48, 49) . This may reflect the high number of individuals from African populations and in particular Khoi San or may be characteristic for the apo(a) gene or both. The frequency of SNPs in this domain of apo(a) may be even 15%) and none of the newly discovered SNPs was frequent. Only the minor allele of the known K IV-10 T66M polymorphism has a frequency >30% in Caucasians (43) . The frequency of 66M is only 11% in South African Blacks and the site is monomorphic in Khoi San. Only two of the SNPs were synonymous whereas all others were nonsynonymous exchanges. Thus, there is a high frequency of non-synonymous exchanges in this region of apo(a). The domain analyzed contains K IV types 6-9 which interact with apoB-100 of LDL and are essential for assembly of Lp(a). Not unexpectedly, several of the polymorphisms had strong and significant effects on Lp(a) concentrations which were independent from the K IV-2 variation and the +93C→T SNP. The substitutions S37F in K IV-6 and G17R in K IV-8, although present with relatively low frequencies in Africans, both showed pronounced decreasing effects on Lp(a) concentrations. On the other hand, the change R18W in K IV-9, which occurred with a frequency of 8% in Khoi San, was associated with Lp(a) levels significantly higher than in the wild-type (defined as the most common allele). Since most described missense mutations are associated with defects in the gene product, it is notable that in this case the amino acid substitution does increase rather than decrease the concentration of a protein. With a frequency of 0.08, it is also unlikely that 18 W is the ancestral allele.
Based on present knowledge, contact with LDL is the only function related to the apo(a) unique K IV types 6-9 and, therefore, the observed effect of the sequence heterogeneity in this region on Lp(a) concentrations could reflect either a modified Lp(a) assembly efficiency or protein instability. The initial non-covalent association between apo(a) and apoB-100 has been shown as a critical step in the Lp(a) particle formation (50) . This process is thought to be mediated by the cooperative action of weak lysine-binding sites (LBS) in K IV types 6, 7 and 8 which are, however, 'masked' in the intact Lp(a) molecule and probably stabilize it (29, (50) (51) (52) . Apo(a) K IV-9, which is predicted to lack a LBS, nevertheless has recently been demonstrated also to participate in the non-covalent contact between apo(a) and LDL (29) . The non-covalent step of the Lp(a) assembly is inhibited by lysine and lysine-analogues (28, 52) but also by arginine, proline and phenylalanine (28, 29) which suggests that in addition to the LBS other sequences might be involved in the non-covalent recognition and interaction with apoB-100. The amino acid changes reported here are outside the predicted lysine binding pockets but may be located within such unidentified domains giving a clue for further in vitro analysis.
Though we have carefully stratified for the affects of the polymorphisms which are known to be causally related to Lp(a) concentrations we can not exclude that some effects observed are due to allelic associations with unidentified mutations in other parts of the gene.
Mutations in regulatory sequences have been related to Lp(a) levels but their effects are much smaller than those observed here and it is unknown whether these polymorphisms exist in African populations. There exist strong linkage disequilibria at the apo(a) locus some of which even extend over the K IV-2 repeat domain of the gene (25) and are present in a wide range of world populations (H.G. Kraft and G. Utermann, unpublished data). This makes any identification of SNP-Lp(a) level association difficult and requires rigorous stratification for potentially confounding variants in apo(a). False positive associations may arise if LD with K IV-2 repeat alleles are not considered but also for other reasons, e.g. by chance. An example is the 'significant' association of the K IV-8 23P allele with Lp(a) levels which were restricted to homozygotes in one population and could not be replicated in another European population.
There are, however, arguments that those mutations identified here as affecting Lp(a) indeed are causal. Two features were common to all missense mutations found to affect Lp(a) levels. First, they occurred in highly conserved regions and introduced amino acids not present at these positions in the other apo(a) kringles or in K IV of plasminogen. Secondly, the amino acid replacements with influence on Lp(a) concentration were non-conservative. Some, like K IV-8 P52L, involved proline residues in the kringle domain and are expected to modify folding of the kringles. Others may change the surface polarity of critical domains, e.g. ligand binding sites. In vitro expression of the mutants will be necessary to clarify whether effects are indeed causal and, if so, which mechanisms underlie the observed effects.
The Lp(a) concentration was influenced only by nonconservative amino acid replacements within the kringles, whereas the V91A and changes in the inter-kringle regions did not show any effects. Since the inter-kringle sequences are highly variable between the different apo(a) K IV types, it may be concluded that this part is less critical for the kringles conformation and hence for their properties. However, the SNPs in this region represent conservative substitutions which may also explain lack of an effect.
The paucity of SNPs in K IV-10 contrasts the frequency of SNPs in the other analyzed type IV kringles. This finding might be incidental but could also indicate that this kringle has functional characteristics which do not tolerate accumulation of mutations. K IV-10 has the highest homology to K IV of plasminogen and shares its pronounced lys-binding capacity. Apo(a) K IV-10 is therefore believed to realize the interaction of Lp(a) with biological substrates like fibrin(ogen) and cell surface receptors (39, (50) (51) (52) .
SNP patterns within the unique kringles of apo(a) differed markedly between populations. No SNP common to Caucasians and Africans was identified in the present study. This indicates that the observed sequence variants in the unique kringles either originated after the split of Africans and non-Africans or that the ancestors of the analyzed African populations did not contribute to the European gene pool. Population-specific SNP patterns have also been observed for other genes (48, 49) but the situation may be unique for the apo(a) gene.
Average Lp(a) levels are 3-fold higher in Africans than in Caucasians. The factors which maintain high Lp(a) levels in African populations are unknown. We noted, however, that those mutations associated with decreased Lp(a) levels in Africans S37F and G17R have low frequencies. In contrast, a splice site mutation in K IV-8 (Table 2 ) resulting in a Lp(a) null type was found to occur with a much higher frequency in Caucasians and was not present in Africans (22) . Furthermore, an SNP associated with Lp(a) concentration above the average R18W was identified only in Africans. Although the identified SNPs certainly cannot explain the difference in the median Lp(a) levels between Africans and Caucasians, the results of this study support the hypothesis that mutations in the coding sequences of apo(a) contribute to the variability of Lp(a) concentrations and may also contribute to differences in Lp(a) levels across populations.
Beyond a better understanding of the apo(a)/Lp(a) system, our results also have a more general implication. They demonstrate that SNPs may have rather subtle effects on a trait which, however, may not be easily detected in other systems. The Lp(a) system may therefore be a valuable model to study the relation between gene variation, effects on functional properties of the gene product, and complex disease (i.e. atherothrombotic disease).
MATERIALS AND METHODS
Population samples
The Caucasian (Tyroleans n = 130) and African (Black South Africans n = 104; Khoi San n = 150) population samples used in this study have been described previously (3) . The number of alleles that were screened by DGGE ranged from 204 to 260 for the Tyroleans, from 182 to 208 for African Blacks and from 98 to 150 for the Khoi San population. Additionally, DNA containing agarose plugs was prepared from EDTA blood according to Kraft et al. (3) from 104 unrelated Finnish individuals collected as a random subset of the population. Lp(a) concentration, geno-and phenotypes of the apo(a) K IV-2 VNTR and other intragenic polymorphisms (e.g. the 5′-PNRP, K IV-10 M66T, and +93C→T) were determined prior to this study for all tested individuals as described elsewhere (3, 21, 23, 43) .
Sequencing of the introns of the unique kringles
Fragments consisting of exons/introns of the unique apo(a) kringles were amplified by PCR according to Mihalich et al. (53) from a YAC clone (ID number ICRFy900C0535) which contains the human apo(a) gene (54) . The PCR products were partially sequenced (see below) with primers used for the corresponding PCR (53) or primers located in the exons (the sequence of the primers is available on request).
PCR amplification and DGGE mutation analysis of the exons of K IV types 6, 8, 9 and 10
The exons of K IV types 6, 8, 9 and 10 were amplified by PCR from genomic DNA with sets of primers shown in Table 1 . For DGGE, the melting profile of the fragments was analyzed by the computer algorithm Melt 87 (55) . According to the optimal predicting melting behavior, GC rich sequences (GC clamps) were included at the 5′ end of one or both primers (Table 1) to obtain the highest sensitivity of mutation detection (42) . The PCR was carried out in 50 µl final volume containing 25 pmol of each primer, 5 µl of the melted DNA plug, 100 µM dNTP (Boehringer Mannheim), 1.5 U DynaZyme II (Finnzymes Oy) and 1× incubation buffer. The reaction was performed through 35 cycles with the following steps: denaturation (94°C) for 40 s, annealing (Table 1) for 40 s and elongation (72°C) for 40 s. The PCR started with the initial denaturation at 94°C for 5 min and finished with a final extension at 72°C for 7 min. The PCR products were concentrated by lyophilization and diluted in 14 µl DGGE loading buffer (20% Ficoll 400, 10 mM Tris-HCl pH 7.5, 1 mM EDTA, 0.25% xylene cyanol and 0.25% bromophenol blue). Prior to the DGGE run, the probes were denatured at 98% C for 3 min and allowed to reanneal at room temperature for 10 min. DGGE was run in 9% polyacrylamide gels for 12-16 h at 80 V (6 V/cm) in 1× TAE buffer.
The electrophoretic equipment was from C.B.S. Scientific Co., model #DGGE-4000. The denaturing conditions were created by 60°C constant temperature of the electrophoresis chamber and urea/formamide gradient in the gel as follows: 14-26% formamide and 2.45-4.55 M urea for exon 1 of K IV-6; 14-30% formamide and 2.45-5.25 M urea for exon 2 of K IV-8; 12-28% formamide and 2.1-4.9 M urea for all other fragments. The gels were stained with ethidium bromide and analyzed under UV light.
PCR-based restriction polymorphism analysis
PCR amplification of exon 1 of K IV-8 was performed in 20 µl total volume as described above. HaeIII digestion of the PCR products was performed according to Prins et al. (44) . The amplicons containing C at position 66 produced two fragments of 108 and 127 bp which were electrophoretically separated on a 2.5% agarose gel.
Direct sequencing of PCR products
The PCR products of interest were purified on Qiaquick columns (Qiagen) and then served as a template for a singlestrand cycle sequencing using Big Dye Terminator Cycle Sequencing Ready Reaction Kit (Perkin-Elmer Corp.). Sequencing reactions were carried out in 40 cycles according to the manufacturer's protocol. After the reaction the probes were purified on Sepharose columns (Perkin-Elmer Corp.) and were analyzed on an ABI PRISM 310 Genetic Analyzer. Each PCR product was sequenced in the forward and reverse direction with the primers used for the corresponding PCR.
Cloning of PCR products
Exons of interest were amplified as described above and cloned in PCR™ 2.1 vector using the Original TA Cloning Kit (Invitrogen). For the PCR, Taq DNA Polymerase (Boehringer Mannheim) generating poly(A) ends was used. The cloning procedures were according to the manufacturer's protocol. The inserts of the identified positive clones were sequenced as described above.
Statistical analysis
An exact test based on the maximum likelihood method was used to generate haplotypes and to test whether the identified polymorphisms were in Hardy-Weinberg equilibrium. The presence of allelic associations was identified by the likelihood ratio test of linkage disequilibrium. The phase of the allelic association was identified using a χ 2 goodness-of-fit test. These calculations were performed using Arlequin (56) .
We used two approaches to test for the significance of an SNP effect on Lp(a) levels. (i) Lp(a) levels of wild-type individuals and hetero-and homozygotes for the respective SNPs were directly compared by the non-parametric Kruskal-Wallis one-way analysis of variance (ANOVA). (ii) Linear multiple regression analysis considering the effect of the K IV-2 VNTR was applied as described (21, 23) to calculate average K IV-2 allele associated Lp(a) levels [designated expected Lp(a) levels] in each population. The effect of a mutation on Lp(a) concentration was then estimated by the difference between measured and expected Lp(a) level and defined as ∆Lp(a). ∆Lp(a) levels were compared between the wild-type and mutant genotypes using Kruskal-Wallis one-way ANOVA. These calculations were performed using the SPSS for Windows package (release 9.0). A difference in Lp(a) levels was only considered significant if (i) both approaches showed significant differences between genotypes at P < 0.05 and (ii) if there was a gene dose effect.
